Jasmine Roth steps in to help me recreate some iconic Starbucks drinks, and things get interesting fast. From foam to syrups ...
Best indoor foam pit jumps compiled for maximum excitement. Kansas mayor hit with criminal charges for allegedly voting as noncitizen in several elections Couple renovating home told by architect a ...
Tripadvisor reviews from the day of Peter's tragic death paint a grim picture of what happened THE devastated family of a dad who died during a “pirate ship” boat trip have claimed “unbothered” staff ...
Around 20 decomposing bodies were discovered in a hidden room concealed by a cardboard display at Davis Mortuary in Pueblo. Investigators believe some of those bodies have been awaiting cremation for ...
The Awareness for Human Rights and Charity Foundation has condemned the actions of a father in Gezawa Local Government Area of Kano State who allegedly abused his children by tying them with ropes and ...
Stephanie Watel is a writer on Game Rant. She has three years of experience writing about all things video games, from news to in-depth guides in a variety of genres. Her strongest niches start with ...
The FDA has approved roflumilast foam 0.3%, a PDE-4 inhibitor, as a once-daily topical treatment for plaque psoriasis in adults and adolescents aged 12 years and older. The drug met both of the ...
Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis ...
The foam formulation of the phosphodiesterase-4 (PDE4) inhibitor roflumilast has been approved by the US Food and Drug Administration (FDA) for treating plaque psoriasis of the scalp and body in ...
There are plenty of different mattresses out there, with each having its own pros, cons, features and more. But which one is suitable for you and your needs? Let us explain. Lindsay Boyers CNET ...
Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients randomized ...
Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. “Use of roflumilast foam was ...